logo
[breadcrumb_custom]

Tag: ARCT Stock

News

Arcturus Therapeutics Holdings Inc (ARCT) Stock: Uncovering 52-Week Market Trends

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Arcturus Therapeutics Holdings Inc’s current trading price is -36.91% away from its 52-week high, while its distance from the 52-week low is 57.76%. The stock’s price range for this time frame has been between $17.52 and $43.81. The trading volume of the company’s shares in the Healthcare reached around 0.61 million for the day, which was evidently higher than the average daily volume of 0.47 million over the last three months. Arcturus Therapeutics Holdings Inc’s stock has seen a

Stock

Behind Arcturus Therapeutics Holdings Inc’s 52-Week Range: Uncovering Opportunities for Investors

Arcturus Therapeutics Holdings Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $43.81 on 02/27/24, while the lowest price for the same duration was marked at $17.52 on 11/13/23. 52-week price history of ARCT Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Arcturus Therapeutics Holdings Inc’s current trading price is -30.15% away from its 52-week high, while its distance from the 52-week low is 74.66%. The stock’s price range during the 52-week period has remained

HCCC Stock
Finance

Arcturus Therapeutics Holdings Inc (ARCT) Stock: Uncovering a 52-Week Range and Trading Volume

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Arcturus Therapeutics Holdings Inc’s current trading price is -24.38% away from its 52-week high, while its distance from the 52-week low is 126.61%. The stock’s price range over this period has fluctuated between $14.62 and $43.81. The company, operating within the financial sector, had a trading volume of approximately 0.59 million for the day, which was noticeably higher than the average daily share volume of 0.42 million over the last 3 months. Arcturus Therapeutics Holdings Inc saw